|
Sep 5
|
Lantheus Appoints Julie Eastland as New Board Member
|
|
Jul 23
|
Dynavax to Report Second Quarter 2024 Financial Results and Host Conference Call on August 6, 2024
|
|
May 14
|
UPDATE 1-US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine
|
|
May 14
|
Dynavax Provides Regulatory Update on sBLA for Four-Dose HEPLISAV-B® Regimen for Adults on Hemodialysis in the U.S.
|
|
May 11
|
Analysts Are Updating Their Dynavax Technologies Corporation (NASDAQ:DVAX) Estimates After Its First-Quarter Results
|
|
May 10
|
Dynavax Technologies Corp (DVAX) Q1 2024 Earnings: Aligns with EPS Projections, Surpasses ...
|
|
May 10
|
Dynavax Technologies First Quarter 2024 Earnings: Misses Expectations
|
|
May 9
|
Dynavax Technologies Corporation (NASDAQ:DVAX) Q1 2024 Earnings Call Transcript
|
|
May 9
|
Dynavax Technologies Corp (DVAX) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue ...
|
|
May 9
|
Dynavax Technologies (DVAX) Q1 2024 Earnings Call Transcript
|
|
May 8
|
Dynavax Technologies (DVAX) Reports Q1 Loss, Misses Revenue Estimates
|
|
May 8
|
Dynavax Reports First Quarter 2024 Financial Results and Provides Business Updates
|
|
Apr 24
|
Dynavax to Report First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
|
|
Apr 21
|
11 Best Low Price Pharma Stocks To Invest In
|
|
Mar 25
|
Those who invested in Dynavax Technologies (NASDAQ:DVAX) five years ago are up 68%
|
|
Mar 5
|
Chief Accounting Officer Justin Burgess Sells Shares of Dynavax Technologies Corp (DVAX)
|
|
Mar 5
|
11 Best Small Cap Pharma Stocks to Invest In
|
|
Jan 9
|
3 Stocks Set to Soar 68% to 200% Higher
|
|
Jan 8
|
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights
|
|
Jan 5
|
Dynavax Technologies (DVAX) Is a Great Choice for 'Trend' Investors, Here's Why
|